NEW YORK, August 15, 2018 /PRNewswire/ --
NetworkNewsWire Editorial Coverage
Despite the scientificallyestablished harmful health effects of smoking, millions of people around the world still do it. Because of this, many large companies are looking for healthier ways to deliver active ingredients from tobacco and cannabis to people with a smoking habit.
Lexaria Bioscience Corp. (CSE:LXX) (OTC:LXRP) (LXRP Profile) is one of the companies looking at alternative solutions, using fatty acids to make a pleasing, fast, effective delivery system for nicotine and cannabidiol (CBD). Tobacco company Altria Group, Inc. (NYSE:MO) is creating lower-risk tobacco products and recently received FDA approval for its latest offering. British American Tobacco Industries p.l.c. ADR (NYSE:BTI) has created a tobacco heater that produces fumes instead of smoke, reducing the potential harm from consumption. GW Pharmaceuticals Plc (NASDAQ:GWPH) has produced a liquid CBD product that is the first U.S. Food and Drug Administration-approved medicine of its type. Most telling of all, Philip Morris International, Inc. (NYSE:PM) has announced a long-term strategy to move away from smoking as the core delivery system for its products - a huge step for a global tobacco giant. Money in Smoking Smoking habits are currently undergoing significant changes. Increased awareness of the dangers of tobacco has led to a decrease in the popularity of cigarette smoking in many parts of the world. Meanwhile, the legalization of cannabis in a growing number of markets is turning marijuana smoking into big business, taking it out of the hands of criminals and attracting innovative pharmaceutical and bioscience companies. But while the growth of the cannabis industry has been welcomed by many, it has raised the same concerns faced by the tobacco industry. Whether cannabis users are looking to benefit from its health-giving properties or to enjoy it as a recreational drug, people who smoke it are exposing themselves to similar risks as other smokers, including lung cancer. If the cannabis industry wants to keep growing and the tobacco industry wants to avoid collapse, both need to find new ways to deliver the benefits of their products while avoiding the proven risks of disease. Alternatives to Smoking
Lexaria Bioscience Corp.'s (CSE:LXX) (OTCQX:LXRP) solution offers a viable alternative. Founded in its current form in 2014, Lexaria may seem like a relative newcomer, but its technology is already providing leaps forward. By focusing on delivery systems for existing compounds, including both nicotine and the active ingredients found in cannabis, the company is developing specialist solutions to serious health problems. Lexaria's main technology is DehydraTECH™. This provides an unusual means for helping the human body absorb beneficial substances and drugs, based on the recognition that many of these molecules are lipophilic, or fat soluble. By combining the drug molecules with fatty acids, DehydraTECH provides a new way for the drugs to enter the body. Lipophilic compounds face a variety of challenges in entering the human body. Isolated from other flavors, they often taste and smell bad, making them off-putting to consume. Once they enter the body, human systems have trouble absorbing them. The compounds are vulnerable to destruction in the stomach and being filtered out by the liver. As a result, they have low bioavailability, or the extent to which they're used by the body. Smoking, vaping and large-dose consumption are all ways of getting around this problem. But DehydraTECH provides another way. It's almost tasteless and odorless, making it palatable for edibles. Being combined with fatty acids makes it easier and faster for the body to aborb, with five to ten times greater absorption through the intestine. Consumption of active compounds through DehydraTECH has two big advantages. First, the consumer avoids smoking and the damage and diseases to the lungs associated with that. Second, the increased and more rapid bioavailability means that a higher amount of the drug molecules are taken in. This reduces the amount people need to consume to gain the benefits, whether medical or recreational. For consumers, DehydraTECH may represent a potential step towards a healthier lifestyle. And for investors, it's a way to enter the tobacco and cannabis markets while avoiding the harm associated with those products - an opportunity to make money while maintaining a clean conscience and reputation. Big News for Nicotine Lexaria recently announced the results of its second in vivo study of 2018 evaluating the use of DehydraTECH as a nicotine delivery system. The results proved the delivery of more nicotine, more quickly, than the positive controls. The study, which was carried out by a third-party laboratory, looked at the absorption of nicotine delivered in an edible form via DehydraTECH. It found that the method led to significantly greater absorption of nicotine: there was 90.2 percent greater absorption within the first 10 minutes using the DehydraTECH system instead of the tested control. Speed of absorption is one of the most important issues for non-inhalation forms of nicotine delivery, given the rapidity with which smoking gets the drug into the body, so this is a strong sign for the potential of DehydraTECH as a smoking alternative. Because it delivers the nicotine so quickly, Lexaria's technology could open the door to entirely new forms of consumer products around the world.
Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com
Corporate Communications Contact: NetworkNewsWire (NNW) New York, New York http://www.NetworkNewsWire.com +212-418-1217 Office Editor@NetworkNewsWire.com Media Contact: FN Media Group, LLC NNW@FinancialNewsMedia.com +1-(954)345-0611
Subscribe to our Free Newsletters!